RO8191 (RO-8191; CDM-3008) is a novel and potent activator of JAK/STAT pathway and interferon α receptor type 2 (IFNAR2) with antiviral effects. It is effective against HCV with EC50 value of 200 nM. RO8191 phosphorylates STAT1 and STAT2, which functions as a gateway to the type I IFN signal cascade, and stimulates the phosphorylation of STAT3, 5 and 6.
Physicochemical Properties
| Molecular Formula | C14H5F6N5O |
| Molecular Weight | 373.212822675705 |
| Exact Mass | 373.039 |
| CAS # | 691868-88-9 |
| PubChem CID | 2768133 |
| Appearance | Off-white to yellow solid powder |
| LogP | 3.7 |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 11 |
| Rotatable Bond Count | 1 |
| Heavy Atom Count | 26 |
| Complexity | 531 |
| Defined Atom Stereocenter Count | 0 |
| SMILES | FC(C1C=C(C(F)(F)F)N=C2C=1C=CC1=NC(C3=NN=CO3)=CN21)(F)F |
| InChi Key | GRHYZVJEXKTJOS-UHFFFAOYSA-N |
| InChi Code | InChI=1S/C14H5F6N5O/c15-13(16,17)7-3-9(14(18,19)20)23-11-6(7)1-2-10-22-8(4-25(10)11)12-24-21-5-26-12/h1-5H |
| Chemical Name | 2-[2,4-bis(trifluoromethyl)imidazo[1,2-a][1,8]naphthyridin-8-yl]-1,3,4-oxadiazole |
| Synonyms | RO8191 CDM-3008 RO 8191 CDM3008 RO-8191 |
| HS Tariff Code | 2934.99.9001 |
| Storage |
Powder-20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month Note: Please store this product in a sealed and protected environment (e.g. under nitrogen), avoid exposure to moisture. |
| Shipping Condition | Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs) |
Biological Activity
| Targets |
|
|
| ln Vitro | CDM-3008, also known as RO8191, exhibits antiviral activity that is reliant on IFNAR2/JAK1 but not IFNAR1/Tyk2. IFNAR2 agonist RO8191 is known to activate IFN signaling in mice [1]. HCV replicon activity was significantly suppressed by RO8191 (0.08, 0.4, 2, 10 μM; for 72 hours) in a dose-dependent way. The HCV NS3 and NS4A protein levels are mostly decreased by RO8191 in the replicon cells' perinuclear area [1]. Viral proteins including NS3, NS4A/B, and NS5A/B vanish when exposed to RO8191 (0.08–10 μM) over 72 hours [1]. | |
| ln Vivo | In the liver of 6-week-old C57BL/6J mice, RO8191 (CDM-3008; 30 mg/kg; oral) dramatically increased the expression of the antiviral genes Oas1b, Mx1, and Pkr [1]. | |
| References |
[1]. An Orally Available, Small-Molecule Interferon Inhibits Viral Replication. Sci Rep. 2012;2:259. [2]. An interferon-like small chemical compound CDM-3008 suppresses hepatitis B virus through induction of interferon-stimulated genes. PLoS One. 2019 Jun 12;14(6):e0216139. |
Solubility Data
| Solubility (In Vitro) | DMSO : ~5 mg/mL (~13.40 mM) |
| Solubility (In Vivo) |
Solubility in Formulation 1: 0.5 mg/mL (1.34 mM) in 10% DMSO + 40% PEG300 + 5% Tween80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), suspension solution; with sonication. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 5.0 mg/mL clear DMSO stock solution to 400 μL PEG300 and mix evenly; then add 50 μL Tween-80 to the above solution and mix evenly; then add 450 μL normal saline to adjust the volume to 1 mL. Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution. Solubility in Formulation 2: 0.5 mg/mL (1.34 mM) in 10% DMSO + 90% (20% SBE-β-CD in Saline) (add these co-solvents sequentially from left to right, and one by one), suspension solution; with ultrasonication. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 5.0 mg/mL clear DMSO stock solution to 900 μL of 20% SBE-β-CD physiological saline solution and mix evenly. Preparation of 20% SBE-β-CD in Saline (4°C,1 week): Dissolve 2 g SBE-β-CD in 10 mL saline to obtain a clear solution. Solubility in Formulation 3: ≥ 0.5 mg/mL (1.34 mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 5.0 mg/mL clear DMSO stock solution to 900 μL of corn oil and mix evenly.  (Please use freshly prepared in vivo formulations for optimal results.) |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 2.6795 mL | 13.3973 mL | 26.7946 mL | |
| 5 mM | 0.5359 mL | 2.6795 mL | 5.3589 mL | |
| 10 mM | 0.2679 mL | 1.3397 mL | 2.6795 mL |